Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association

MJ Feinstein, PY Hsue, LA Benjamin, GS Bloomfield… - Circulation, 2019 - Am Heart Assoc
As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

HIV infection and coronary heart disease: mechanisms and management

PY Hsue, DD Waters - Nature Reviews Cardiology, 2019 - nature.com
Antiretroviral therapy has largely transformed HIV infection into a chronic disease condition.
As such, physicians and other providers caring for individuals living with HIV infection need …

[HTML][HTML] Effect of universal testing and treatment on HIV incidence—HPTN 071 (PopART)

RJ Hayes, D Donnell, S Floyd, N Mandla… - … England Journal of …, 2019 - Mass Medical Soc
Background A universal testing and treatment strategy is a potential approach to reduce the
incidence of human immunodeficiency virus (HIV) infection, yet previous trial results are …

[HTML][HTML] HIV testing and treatment with the use of a community health approach in rural Africa

DV Havlir, LB Balzer, ED Charlebois… - … England Journal of …, 2019 - Mass Medical Soc
Background Universal antiretroviral therapy (ART) with annual population testing and a
multidisease, patient-centered strategy could reduce new human immunodeficiency virus …

[HTML][HTML] ADAPT: an algorithm incorporating PRO‐C3 accurately identifies patients with NAFLD and advanced fibrosis

SJ Daniels, DJ Leeming, M Eslam, AM Hashem… - Hepatology, 2019 - journals.lww.com
The role of antiretroviral therapy (ART) in reducing or contributing to liver fibrosis in persons
with human immunodeficiency virus (HIV) is unclear. We evaluated participants in the …

[HTML][HTML] Universal testing, expanded treatment, and incidence of HIV infection in Botswana

J Makhema, KE Wirth, M Pretorius Holme… - … England Journal of …, 2019 - Mass Medical Soc
Background The feasibility of reducing the population-level incidence of human
immunodeficiency virus (HIV) infection by increasing community coverage of antiretroviral …

Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society–USA Panel

HF Günthard, V Calvez, R Paredes… - Clinical Infectious …, 2019 - academic.oup.com
Background Contemporary antiretroviral therapies (ART) and management strategies have
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …

Screening for HIV infection: US preventive services task force recommendation statement

DK Owens, KW Davidson, AH Krist, MJ Barry… - Jama, 2019 - jamanetwork.com
Importance Approximately 1.1 million persons in the United States are currently living with
HIV, and more than 700 000 persons have died of AIDS since the first cases were reported …

[HTML][HTML] The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment

S Baral, A Rao, P Sullivan, N Phaswana-Mafuya… - The lancet HIV, 2019 - thelancet.com
In 2019, the HIV pandemic is growing and soon over 40 million people will be living with
HIV. Effective population-based approaches to decrease HIV incidence are as relevant as …

Effect estimates in randomized trials and observational studies: comparing apples with apples

S Lodi, A Phillips, J Lundgren, R Logan… - American journal of …, 2019 - academic.oup.com
Abstract Effect estimates from randomized trials and observational studies might not be
directly comparable because of differences in study design, other than randomization, and in …